AB

Anjna Bhatia

Active Director Director DIN 10177339
DIN 10177339 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Anjna Bhatia

Data last updated:

Anjna Bhatia is a Director at Medzy Healthcare Private Limited (since 2023). The company operates in Pharma. Medzy Healthcare Private Limited reported revenue of ₹2.07 Cr (FY 2024).

DIN 10177339
Primary Designation Director
Industry Pharma
First Appointment 26 May 2023
Oldest Company Age 3 yrs
Largest company Medzy Healthcare Private Limited · ₹2.07 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medzy Healthcare Private Limited U46497DL2023PTC414698
Director26 May 20232023₹2.07 Cr (FY 2024)Active

Board colleagues of Anjna Bhatia

NameDINCompanyDesignation
Tushar Bhatia10177340Medzy Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medzy Healthcare Private Limited
Premium access

Shareholding and investment profile for Anjna Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjna Bhatia

Anjna Bhatia currently holds 1 directorship: Medzy Healthcare Private Limited (Director, since 26 May 2023, revenue ₹2.07 Cr (FY 2024)).

Anjna Bhatia was first appointed on 26 May 2023 as Director at Medzy Healthcare Private Limited.

The current boards of Anjna Bhatia's companies include Tushar Bhatia (Medzy Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available